These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 32150970)

  • 1. Sepsis-Associated Encephalopathy: From Delirium to Dementia?
    Chung HY; Wickel J; Brunkhorst FM; Geis C
    J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32150970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofilament light chains to assess sepsis-associated encephalopathy: Are we on the track toward clinical implementation?
    Bircak-Kuchtova B; Chung HY; Wickel J; Ehler J; Geis C
    Crit Care; 2023 May; 27(1):214. PubMed ID: 37259091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis and the brain: a review for acute and general physicians.
    Carter BL; Underwood J
    Clin Med (Lond); 2022 Sep; 22(5):392-395. PubMed ID: 36507825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A summary of the current diagnostic methods for, and exploration of the value of microRNAs as biomarkers in, sepsis-associated encephalopathy.
    Yuechen Z; Shaosong X; Zhouxing Z; Fuli G; Wei H
    Front Neurosci; 2023; 17():1125888. PubMed ID: 37008225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight Into Regulatory T Cells in Sepsis-Associated Encephalopathy.
    Gao YL; Liu YC; Zhang X; Shou ST; Chai YF
    Front Neurol; 2022; 13():830784. PubMed ID: 35370925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepsis Associated Encephalopathy.
    Chaudhry N; Duggal AK
    Adv Med; 2014; 2014():762320. PubMed ID: 26556425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioenergetics, mitochondrial dysfunction, and oxidative stress in the pathophysiology of septic encephalopathy.
    Bozza FA; D'Avila JC; Ritter C; Sonneville R; Sharshar T; Dal-Pizzol F
    Shock; 2013 May; 39 Suppl 1():10-6. PubMed ID: 23481496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentially modifiable factors contributing to sepsis-associated encephalopathy.
    Sonneville R; de Montmollin E; Poujade J; Garrouste-Orgeas M; Souweine B; Darmon M; Mariotte E; Argaud L; Barbier F; Goldgran-Toledano D; Marcotte G; Dumenil AS; Jamali S; Lacave G; Ruckly S; Mourvillier B; Timsit JF
    Intensive Care Med; 2017 Aug; 43(8):1075-1084. PubMed ID: 28466149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical perspective of sepsis-associated delirium.
    Tsuruta R; Oda Y
    J Intensive Care; 2016; 4():18. PubMed ID: 27011789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sepsis-associated encephalopathy.
    Gofton TE; Young GB
    Nat Rev Neurol; 2012 Oct; 8(10):557-66. PubMed ID: 22986430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sepsis-associated encephalopathy: not just delirium.
    Zampieri FG; Park M; Machado FS; Azevedo LC
    Clinics (Sao Paulo); 2011; 66(10):1825-31. PubMed ID: 22012058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-hepatic Hyperammonemia: A Potential Therapeutic Target for Sepsis-associated Encephalopathy.
    Zhao L; Li Y; Wang Y; Ge Z; Zhu H; Zhou X; Li Y
    CNS Neurol Disord Drug Targets; 2022; 21(9):738-751. PubMed ID: 34939553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepsis-Associated Encephalopathy: A Mini-Review of Inflammation in the Brain and Body.
    Ito H; Hosomi S; Koyama Y; Matsumoto H; Imamura Y; Ogura H; Oda J
    Front Aging Neurosci; 2022; 14():912866. PubMed ID: 35711904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral dysfunctions caused by sepsis during ageing.
    Manabe T; Heneka MT
    Nat Rev Immunol; 2022 Jul; 22(7):444-458. PubMed ID: 34764472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglia: A Potential Therapeutic Target for Sepsis-Associated Encephalopathy and Sepsis-Associated Chronic Pain.
    Li Y; Yin L; Fan Z; Su B; Chen Y; Ma Y; Zhong Y; Hou W; Fang Z; Zhang X
    Front Pharmacol; 2020; 11():600421. PubMed ID: 33329005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study.
    Girard TD; Thompson JL; Pandharipande PP; Brummel NE; Jackson JC; Patel MB; Hughes CG; Chandrasekhar R; Pun BT; Boehm LM; Elstad MR; Goodman RB; Bernard GR; Dittus RS; Ely EW
    Lancet Respir Med; 2018 Mar; 6(3):213-222. PubMed ID: 29508705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study.
    Ehler J; Petzold A; Wittstock M; Kolbaske S; Gloger M; Henschel J; Heslegrave A; Zetterberg H; Lunn MP; Rommer PS; Grossmann A; Sharshar T; Richter G; Nöldge-Schomburg G; Sauer M
    PLoS One; 2019; 14(1):e0211184. PubMed ID: 30677080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The spectrum of encephalopathy in critical illness.
    Stevens RD; Pronovost PJ
    Semin Neurol; 2006 Sep; 26(4):440-51. PubMed ID: 16969745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive strategies and potential therapeutic interventions for delirium in sepsis.
    Souza-Dantas VC; Póvoa P; Bozza F; Soares M; Salluh J
    Hosp Pract (1995); 2016 Oct; 44(4):190-202. PubMed ID: 27223862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sepsis-Associated Encephalopathy: from Pathophysiology to Progress in Experimental Studies.
    Catarina AV; Branchini G; Bettoni L; De Oliveira JR; Nunes FB
    Mol Neurobiol; 2021 Jun; 58(6):2770-2779. PubMed ID: 33495934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.